1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Autoimmune Drug Focus JUNE 2015

Autoimmune Drug Focus JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Systemic Sclerosis Indication Will Make Actemra A Cornerstone Product For Roche
Industry Brief - FDA Approves Lilly's Humalog U-200 KwikPen
Industry Brief - Basal Insulin Peglispro Shows Superiority Over Insulin Glargine In Phase III Studies
Industry Brief - TiGenix Starts Cx601 MAA Process
Industry Brief - RedHill's RHB-104 Phase III Trial Application Accepted In Europe For CD
Industry Trend Analysis - Copaxone 20mg's US Sales To Drop At Least 80%
Industry Brief - Quebec Government To Cover Tecfidera As A First-Line Oral Treatment For MS
Industry Brief - Patient Enrolment Completed In Phase IIa Study Of RHB-104 For MS
Industry Brief - Adamas Begins ADS-5102 Phase II Trial In MS Patients With Walking Impairment
Industry Trend Analysis - Biosimilars Will Be Essential In Future RA Treatment Options
Industry Brief - NICE Recommends Stelara For Active PsA
Industry Brief - First Biosimilar Infliximab Approved In Brazil
Industry Brief - Post Hoc Analysis Of Orencia Plus MTX Phase IIIb Data In Patients With RA Unveiled
Industry Brief - Phase III Results For Lesinurad+Febuxostat In Tophaceous Gout Patients Presented
Industry Brief - Novartis Announces New One-Year Results Demonstrating Sustained Secukinumab Efficacy In AS
Industry Brief - Positive Phase III Results With Cimzia In DMARD-Naïve RA Patients Presented
Industry Brief - Evaluated Data On Otezla For Long-Term Improvement In Enthesitis And Dactylitis Presented
Industry Brief - Humira Phase III Study Shows Promise In Paediatric Severe Chronic Plaque Psoriasis
Industry Brief - Glenmark Gains US Calcipotriene Cream Approval
Industry Brief - Akaal Receives Approval To Initiate Phase II Psoriasis Trial Of Topical AKP-11
Industry Trend Analysis - GSK Agreement Will Raise Padlock's Partnering And Acquisition Profile
Industry Brief - Baxter Ventures/Mayo Clinic/VPD Form Vitesse Biologics
Industry Brief - amp Out-Licenses Second Biosimilar
Industry Trend Analysis - Additional Indication Will Strengthen Promacta's Position As A Niche Drug
Industry Trend Analysis - Astellas Branches Out Into Autoimmune Sphere Through Anokion Agreement
Industry Brief - Kezar Raises Funds To Advance Treatments For Autoimmune Disorders
Industry Brief - Autoimmune Conferences - September 2015

Table Of Contents

Autoimmune Drug Focus JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the Netherlands

  • January 2017
    5 pages
  • Therapy  

  • Netherlands  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Anti-Infective Market in India

  • January 2017
    4 pages
  • Anti-Infective  

    Blood Disease  

  • India  

    United States  

View report >

Therapy Market

1 day ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.